Wednesday, November 02, 2005

Vaginal atrophy drug Ospemifine may fight breast cancer

United Press International, November 2, 2005
Ospemifine, a tamoxifen-like drug now in clinical testing to treat vaginal atrophy may also help prevent breast cancer. The researchers said two mice studies found that ospemifine may fight cancer in addition to reducing vaginal atrophy, a condition that affects up to 40 percent of post-menopausal women.


Post a Comment

<< Home

/* WebRing Code */